Violeta García-Hernández

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Cell Proliferation

Locally Advanced

Squamous Cell Carcinoma

Acute Lymphoblastic Leukemia

Top Venues

EMBO molecular medicine

The EMBO journal

This page only lists publications with an associated author ORCID identifier.

Publications

Violeta García-Hernández, David Arambilet, Yolanda Guillén, Teresa Lobo-Jarne, Maria Maqueda, Christos Gekas, Jessica González, Arnau Iglesias, Nerea Vega-García, Inés Sentís, Juan L Trincado, Ian Márquez-López, Holger Heyn, Mireia Camós, Lluís Espinosa, Anna Bigas
β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia. EMBO molecular medicine (2023)
Violeta García-Hernández, David Arambilet, Yolanda Guillén, Teresa Lobo-Jarne, Maria Maqueda, Christos Gekas, Jessica González, Arnau Iglesias, Nerea Vega-García, Inés Sentís, Juan L Trincado, Ian Márquez-López, Holger Heyn, Mireia Camós, Lluís Espinosa, Anna Bigas
β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia. EMBO molecular medicine 15 (2) (2023)
Irene Pecharromán, Laura Solé, Daniel Alvarez-Villanueva, Teresa Lobo-Jarne, Josune Alonso-Marañón, Joan Bertran, Yolanda Guillén, Ángela Montoto, María Martínez-Iniesta, Violeta García-Hernández, Gemma Giménez, Ramon Salazar, Cristina Santos, Marta Garrido, Eva Borràs, Eduard Sabidó, Ester Bonfill-Teixidor, Raffaella Iurlaro, Joan Seoane, Alberto Villanueva, Mar Iglesias, Anna Bigas, Lluís Espinosa
IκB kinase-α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapy. The EMBO journal (2023)
Violeta García-Hernández, David Arambilet, Yolanda Guillén, Teresa Lobo-Jarne, Maria Maqueda, Christos Gekas, Jessica González, Arnau Iglesias, Nerea Vega-García, Inés Sentís, Juan L Trincado, Ian Márquez-López, Holger Heyn, Mireia Camós, Lluís Espinosa, Anna Bigas
β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia. EMBO molecular medicine 15 (2) (2023)
Violeta García-Hernández, David Arambilet, Yolanda Guillén, Teresa Lobo-Jarne, Maria Maqueda, Christos Gekas, Jessica González, Arnau Iglesias, Nerea Vega-García, Inés Sentís, Juan L Trincado, Ian Márquez-López, Holger Heyn, Mireia Camós, Lluís Espinosa, Anna Bigas
β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia. EMBO molecular medicine 15 (2) (2023)
Violeta García-Hernández, David Arambilet, Yolanda Guillén, Teresa Lobo-Jarne, Maria Maqueda, Christos Gekas, Jessica González, Arnau Iglesias, Nerea Vega-García, Inés Sentís, Juan L Trincado, Ian Márquez-López, Holger Heyn, Mireia Camós, Lluís Espinosa, Anna Bigas
β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia. EMBO molecular medicine 15 (2) (2023)
Violeta García-Hernández, David Arambilet, Yolanda Guillén, Teresa Lobo-Jarne, Maria Maqueda, Christos Gekas, Jessica González, Arnau Iglesias, Nerea Vega-García, Inés Sentís, Juan L Trincado, Ian Márquez-López, Holger Heyn, Mireia Camós, Lluís Espinosa, Anna Bigas
β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia. EMBO molecular medicine 15 (2) (2023)
Miguel Alejandro Galindo-Campos, Nura Lutfi, Sarah Bonnin, Carlos Manuel Martínez, Talía Velasco-Hernandez, Violeta García-Hernández, Juan Martin-Caballero, Coral Ampurdanés, Ramón Gimeno, Lluis Colomo, Gael Roue, Guillaume Guilbaud, Françoise Dantzer, Pilar Navarro, Matilde Murga, Oscar Fernandez-Capetillo, Anna Bigas, Pablo Menendez, Julian Sale, José Yélamos
Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice. Blood (2021)